Small Molecule Oxybutynin Rescues Proliferative Capacity of Complex III-Defective Muscle Progenitor Cells
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00141.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Yue Qu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nutritional Sciences, Cornell University, Ithaca, New York, United States. Hauptthemen laut MEDLINE: Mandelic Acids, Cell Proliferation, Stem Cells, Muscle, Skeletal. Gefördert von: Hartwell Foundation (HARTWELL), Presidents Council of Cornell Women (PCCW).
Abstract (Originalsprache)
Mitochondrial disease encompasses a group of genetically inherited disorders hallmarked by an inability of the respiratory chain to produce sufficient ATP. These disorders present with multisystemic pathologies that predominantly impact highly energetic tissues such as skeletal muscle. There is no cure or effective treatment for mitochondrial disease. We have discovered a small molecule known as oxybutynin that can bypass Complex III mitochondrial dysfunction in primary murine and human skeletal muscle progenitor cells (MPCs). Oxybutynin administration improves MPC proliferative capacity, enhances cellular glycolytic function, and improves myotube formation. Mechanistically, results from our isothermal shift assay indicates that oxybutynin interacts with a suite of proteins involved in mRNA processing which then trigger the upregulation biological pathways to circumvent CIII mitochondrial dysfunction. Taken together, we provide evidence for the small molecule oxybutynin as a potential therapeutic candidate for the future treatment of CIII mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nutritional Sciences, Cornell University, Ithaca, New York, United States.
- College of Veterinary Medicine, Cornell University, Ithaca, New York, United States.
- Bindley Bioscience Center, Purdue University, West Lafayette, Indiana, United States.
- Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States.
- Department of Biochemistry and Molecular Biology, Michigan State University, Lansing, Michigan, United States.
ORCID-Profile: Kaydine Edwards, Muying Li, Matthew Williams, Pei-Yin Tsai, Chloe Cheng, Jamie Blum, Noel Acor, Anna Thalacker-Mercer, Aleksandra Skirycz, Joeva J Barrow
Förderung
- Hartwell Foundation (HARTWELL)
- Presidents Council of Cornell Women (PCCW)
Zitieren
APA
Qu, Y., Edwards, K., Li, M., Williams, M., Liu, Y., Tsai, P. Y., Cheng, C., Blum, J., Acor, N., Oshoe, T., Walter, C., Thirumalaikumar, V., Thalacker-Mercer, A., Skirycz, A., & Barrow, J. J. (2025). Small Molecule Oxybutynin Rescues Proliferative Capacity of Complex III-Defective Muscle Progenitor Cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00141.2025
Vancouver
Qu Y, Edwards K, Li M, Williams M, Liu Y, Tsai PY, et al. Small Molecule Oxybutynin Rescues Proliferative Capacity of Complex III-Defective Muscle Progenitor Cells. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00141.2025
BibTeX
@article{Qu2025,
author = {Qu, Yue and Edwards, Kaydine and Li, Muying and Williams, Matthew and Liu, Yang and Tsai, Pei-Yin and Cheng, Chloe and Blum, Jamie and Acor, Noel and Oshoe, Tenzin and Walter, Claire and Thirumalaikumar, Venkatesh and Thalacker-Mercer, Anna and Skirycz, Aleksandra and Barrow, Joeva J},
title = {Small Molecule Oxybutynin Rescues Proliferative Capacity of Complex III-Defective Muscle Progenitor Cells},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00141.2025}
}
EUVIMED